Zepbound is off to a good start, but here's what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…
Novo Nordisk A/S
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…